Resultados de la búsqueda 451-460 de 3475 para anti-TNF drugs

  1. Terapia hormonal de feminización - Mayo Clinic

    Gender-affirming hormone therapy (adult). Mayo Clinic; 2022. Nippoldt TB (expert opinion). Mayo Clinic. Feb. 7, 2024. Relacionado. Disforia de género ...

  2. Oncología (médica) - Ensayos clínicos

    Anti-cancer activity will be assessed every 6 weeks during therapy and every 12 weeks thereafter. Establishment of Preclinical Models from Patients with ...

  3. Cirugía - Ensayos clínicos - Mayo Clinic

    The purpose of this study is to compare two types of surgery for the treatment of uterovaginal prolapse to determine which surgery works best from a ...

  4. Radiología - Ensayos clínicos - Mayo Clinic

    ... treatment. A Study to Evaluate Potential Myocardial Injury Following Magnetic Resonance Imaging (MRI). Rochester, Minn. The purpose of this study is to ...

  5. Cirugía - Ensayos clínicos - Mayo Clinic

    ... treatment, post-treatment and (when available) post-mortem soft tissue sarcoma (STS) tissue and tissue data with an emphasis on STSs occurring in younger ...

  6. Cirugía - Ensayos clínicos - Mayo Clinic

    To determine the effectiveness of the ARTISAN Aphakia lens in the treatment of aphakia and to precisely define the associated risks and, if possible, identify ...

  7. Salud de la mujer - Mayo Clinic

    Drugs that kill "zombie" cells may benefit some older women, but not all ... Hormone therapy: Four things a Mayo Clinic women's health specialist wants ...

  8. Oncología (médica) - Ensayos clínicos

    Giving vinorelbine and VAC may kill more tumor cells. Adding maintenance therapy (vinorelbine and cyclophosphamide) after VAC therapy, with or without ...

  9. La salud de adolescentes y preadolescentes Noticias de la Mayo Clinic

    News · julio 2024 · junio 2024 · mayo 2024 · abril 2024 · marzo 2024 · febrero 2024 · enero 2024 · diciembre 2023.

  10. Oncología (médica) - Ensayos clínicos

    A Study to Test the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) with One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary ...